Ribavirin;La ribavirina

GIMT - Giornale Italiano delle Malattie del Torace

Volumn 57, Issue 1, 2003, Pages 31-42

  Blasi, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADENOVIRUS 2; ADENOVIRUS 5; AFRICAN SWINE FEVER VIRUS; ANTIVIRAL ACTIVITY; AREA UNDER THE CURVE; ARENAVIRUS; BIRNAVIRIDAE; CALICIVIRUS; CARCINOGENICITY; CYTOMEGALOVIRUS; DRUG ABSORPTION; DRUG METABOLISM; DRUG STRUCTURE; HEMOLYTIC ANEMIA; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IRIDOVIRUS; MARDIVIRUS; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MUSCLE RIGIDITY; MUTAGENICITY; MYXOMA VIRUS; NONHUMAN; ORTHOMYXOVIRUS; PARAMYXOVIRUS; PICORNAVIRUS; PSEUDORABIES HERPETOVIRUS; REOVIRUS; RETROVIRUS; REVIEW; RHABDOVIRUS; TIME TO MAXIMUM PLASMA CONCENTRATION; TOGAVIRUS; VACCINIA VIRUS; VIRUS INFECTION; VIRUS INHIBITION;

EID: 33747877421     PISSN: 11270810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Streeter, D.G., J.T. Witkouski, G.P. Khare, et al. "Mechanism of action of 1-beta-D-ribofuranosyl-1,2,4-tiazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent." Proc. Natl. Acad. Sci.(USA) 1973; 70: 1174-1178.
2. Browne, MJ. "Mechanism of action of ribavirin." Antimicrob. Agents Chemo. 1978; 15: 747-753.
3. Zimmerman, T.P., and Deeprose, R.D. "Metabolism of 5-amino-beta-D-ribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5′-triphosphates in human blood and L5178Y cells". Biochem. Pharmacol. 1978; 27: 709-716.
4. Smith, R.A. "Mechanism of action of ribavirin." In: Ribavirin a broad spectrum antiviral agent. R.A. Smith and W.Kirpatrick (eds.) Academic Press, New York, 1980, pp. 59-71.
5. Eriksson, B., E. Helgstrand, N.G. Johansson , et al. "Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate." Antimicrob. Agents Chemo. 1977; 11: 946-951.
6. Hillyard, I.N. "The preclinical toxicology and safety of ribavirin." In: Ribavirin: a broad spectrum antiviral agent. R.A. Smith and W. Kirkpatrick (eds.) Academic Press, New York, 1980, pp. 59-71.
7. Canonico, P.G. "Ribavirin. A review of efficacy, toxicity and mechanisms of antiviral activity." In: Antibiotics. Vol VI. Modes and mechanisms of Microbiol. Growth inhibitors. F.E. Hahn (ed.) Springer-Verlag, Berlin, Heidelberg, 1983, pp. 161-186.
8. Smith, R.A., and W, Kirkpatrick. "The pharmacology of ribavirin." In: Developments in antiviral therapy. L. H. Collier and J. Oxford (Eds.) Academic Press, London. 1980, pp. 133-156.
9. Sidwell, R.W., M.J. Ellenhorn, I. W. Hillyard, and J. M. Lima. "Safety Evaluations of the broad-spectrum antiviral agent ribavirin (Virazole." Current Chemo. 1980; 4: 353-338.
10. Fern, V.H., C. Willhite, and L. Kilham. "Teratogenic effect of ribavirin on hamster and rat embryos." Teratol. 1978; 17: 93-102.
11. Kochhar, D.M., J.D. Penner, and T. B. Kundsen. "Embroytoxic, teratogenic and metabolic effects of ribavirin in mice." Toxicol, and Applied Pharmacol. 1980; 52: 99-112.
12. Sidwell, R.W., R.K. Robins, and I.W. Hillyard. "Ribavirin: an antiviral agent." Pharmacol. Ther. 1979; 6: 123-146.
13. Miller, J.P., L.J. Kiwana, D.G. Streeter, et al. "The relationship between the metabolites of ribavirin and its proposed mechanism of action." Ann N.Y. Acad. Sci. 1977; 284: 211-229.
14. Carlin, D.H., R.A. Smith, aand A.I. Samuels. "14C-ribavirin: Distribution and pharmacokinetic studies in rats, baboons and man." In: Ribavirin: A broad spectrum a antiviral agent. R.A. Smith and W. Kirkpatrick (eds.) Academic Press, New York. 1980; 19: 83-89.
15. Canonico, P.G., M. Kende, and J.W. Huggins. "The toxicology and pharmacology of ribavirin in experimental animals." In: Clinical applications of ribavirin. R.A. Smith, V. Knight and J.A.D. Smith (eds.) Academic Press, New York, 1984, pp. 65-77.
16. Huffman, J.H., R.W. Sidwell. G.P. Khare, et al. "In vitro effect of 1-beta-D- ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole, ICN-1229) on deoxyribonucleic acid and ribonucleic acid viruses." Antimicrob. Agents Chemo. 1973; 3: 235-241.
17. Saganuma, T. and N. Ishida. "An evaluation of a new antiviral agent 'Virazole' against influenza virus infections." Tohoku J. Exp. Med. 1973; 110: 405-406.
18. Drach, J.C. and Shipman Jr. "The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness." Ann. N.Y. Acad. Sci. 1977;284:396-409.
19. Drach, J.C., M.A. Thomas and C. Shipman Jr. "Ribavirin inhibition of thymideine phosphorylation in KB cells." Ann. Mtg. Amer. Soc. Microbiol. 1978, p. 7.
20. Togo, Y. "In vitro effect of Virazole against influenza viruses." Antimicrob. Agents Chemo. 1973; 4: 641-642.
21. Sidwell, R.W., J.H. Huffman, G.P. Khare, et al. "Broadspectrum antiviral activity of Virazole: 1-beta-D-ribofuransyl-1,2,4-triazole-3- carboxamide." Science. 1972;177:705-706.
22. Durr, F.E., and H.F. Lindh. "Efficacy of ribavirin against influenza virus in tissue culture and in mice." Ann. N.Y. Acad. Sci. 1975; 255: 366-371.
23. Appleyard, G., and H.B. Maber. "A plaque assay for study of influenza virus inhibitors." In: Chemotherapy and control of influenza. J.S. Oxford and J.D. Williams (eds.) Academic Press, London. 1976, pp. 49-53.
24. Tisdale, M., and D.J.Bauer. "A comparison of test methods in influenza chemotherapy." In: Chemotherapy and control of influenza. J. S. Oxford and J.D. Williams (eds.) Academic Press, London. 1976.
25. Tisdale, M. and D.J. Bauer. "The relative potencies of anti-influenza compounds." Ann. N.Y. Acad. Sci. 1977; 284: 254-263.
26. Browne, M.J., M.Y. Moss, and M.R. Boyd. "Comparative activity of amantadine and ribavirin against influenza virus in vitro: Possible clinical relevance." Antimicrob. Agents Chemo. 1983; 23: 503-505.
27. Shigeta, S., S. Mori, B. Masanori, et al. "Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6′-(R)-6′-C-methylneplanocin A, against several ortho- and para-mixoviruses." Antimicrob. Agents Chemo. 1992; 36: 435-439.
28. Browne, M.J. "Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MOCK cells." Antimicrob. Agents Chemo. 1981; 19: 712-715.
29. Lindsay, H.L., and B.R. Nelsen. "Effect of ribavirin on replication of influenza viruses in rhesus monkeys tracheal organ cultures." Abstract A28. Annual Mtg. Amer. Soc. Microbiol. 1975.
30. Arroyo, V.M., and S.E. Reed. "The use of Ferret trachea organ cultures for therapeutic studies of anti-influenza drugs. Comparison of Foure compounds in tissue culture and in organ culture." J. Antimicrob. Chemo. 1978; 4: 263-271.
31. Smee, D.F., W. Sidwell, B.B. Barnett, et al. "Development of antiviral levels of ribavirin in serum and urine of orally treated rats." Chemo. 1981; 27:12-17.
32. Hruska, J.F., J,M. Bernstein, R.G. Douglas, Jr., and C.B. Hall. "Effects of ribavirin on respiratory syncytial virus in vitro." Antimicrob. Agents Chemo. 1980; 17: 770-775.
33. Kawana, F., S. Shigeta, M. Hosoya, et al. "Inhibitory effects of antiviral compounds in respiratory syncytial virus replication in vitro." Antimicrob. Agents Chemo. 1987; 31: 1225-1230.
34. Kang, J-O, and C.H. Pai. "In situ enzyme immunoassay for antiviral susceptibility testing of respiratory syncytial virus." Amer. J. Clin. Pathol. 1989; 91: 323-326.
35. Sidwell, R.W., L.N. Simon, J.T. Witkowski, and R.K. Robins. "Antiviral activity of Virazole: Review and structure activity relationships." Proc. 8th Intl. Cong. Chemo. Athens, Greece. Prog. In Chemo. 1974; 2: 889-903.
36. Balzarini, J., C.-K., Lee, P. Herdewijn, and E. DeClerq. "Mechanism of the potentiating effect of ribavirin on the activity of 2′3′- dideoxylnosine against human immunodeficiency virus." J. Biol. CHem. 1991;266:21509-21514.
37. Balzarini, J., H. Mitsuya, E. DeClerq, and S. Broder. "Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cells limphotropic virus (HTLV-III) lymphadenopathy-associated virus (LAV)." Intl. J. Cancer 1986; 37: 451-457.
38. Balzarini, J., P. Herdewijn, and E. DeClerq. "Potentiating effects of ribavirin on the antiretrovirus activity of 1′-azido-2,6-diaminopurine- 2,3-dideoxyriboside in vitro and in vivo. Antiviral Res. 1989; 11: 161-172.
39. Fernandez-Larsson, R., and J.L. Patterson. "Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase." Molec. Pharm. 1990; 38: 766-770.
40. Snell, N.J.C. Review: Antiviral portrait series, Number 2. "The activity of ribavirin against the human immunodeficiency virus: A review of laboratory and clinical experience." Antiviral Chem. and Chemo. 1991; 2: 257-263.
41. Sidwell, R.W., and D.F Smee. "Bovine leukemia virus inhibition in vitro by ribavirin." Antiviral Res. 1981; 1: 47-53.
42. Allen, L.B., S.M. Wold, C.J. Hintz, et al. "Effect of ribavirin on type 2 herpes virus hominis (HVH/2) in vitro and in vivo." Ann. N.Y. Acad. Sci. 1977; 284: 247-253.
43. Edison, C.S., V.T. Than, and S.H. Kleven. "The in vitro and in vivo effect of chemotherapeutic agents on the Marek's disease herpesvirus of chickens." Poultry Science. 1974;53:1533-1538.
44. Dowling , J.N., B. Postic, and L.O. Guevara. "Effect of ribavirin on murine cytomegalovirus infection ." Antimicrob. Agents Chemo. 1976; 10: 809-813.
45. Povey, R.C. "In vitro antiviral efficacy of ribavirin against feline calcivirus, feline viral rhinotracheitis virus and canine parainfluenza virus." Am. J. Vet. Res. 1978; 39: 175-178.
46. Katz, E., E. Margalith, and B. Winer. "Inhibition of vaccinia virus growth by the nucleoside analog 1-beta-D-ribofuranosyl-1,2,4,-triazole-3- carboxamide (Virazole, ribavirin). J. Gen. Virol. 1976;32:327-330.
47. Scheffler, P., D. Haghchenas, and R. Wigand. "The effect of purine and pyrimidine analogues and Virazole on adenovirus replication." Acta Virol. 1975; 19: 105-115.
48. Gil-Fernandez, C., and E.R. Declerq. "Comparative efficacy of broad-spectrum antiviral agents as inhibitors of African swine fever virus replication in vitro." Antiviral Res. 1987; 7: 151-160.
49. Hayden, F.G., R.G. Douglas Jr., and R. Simons. "Enhancement of activity against influenza viruses by combination of antiviral agents." Antimicrob. Agents Chemo. 1980; 18: 536-541.
50. Galegov, G.A., V. Knight, N.L. Pushkarskaya, et al. "Investigation of the combined effect of rimantidine (Amantidine) and ribavirin on experimental influenza infection." Vopr. Virusol. 1981; 6: 697-700.
51. Pushkarskaya, N.L., N.D. L'vov and G.A. Galegov. "Prevention of formation of influenza A virus mutant reistant to rimantadine (hydrochloride alpha-methyl-1,2,4-triazole-3-carboxamide)." Vopr. Virusol. 1980; 0(3): 303-306.
52. Koff, W.C., J.L. Elm Jr., and S.B. Halstead. "Antiviral effects of ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine againstn dengue viruses in vitro." Antivir. Res. 1982; 2: 69-72.
53. Huggins, J.W., R.K. Robins, and P.G. Canonico. "Synergistic antiviral effects of ribavirin and the C-nucleoside analogues tiazofurin and selenazofurin against togaviruses, bunyaviruses and arenaviruses." Antimicrob. Agents Chemo. 1984; 26: 476-480.
54. Huggins, J.W., P. Jahrling, M. Kende, et al. "Efficacy of ribavirin against virulent RNA virus infections." In: Clinical applications of ribavirin. R.A. Smith, V. Knight, and J.A.D. Smith (eds.) Academic Press, New York. 1984, pp. 49-63.
55. Vogt, M.W., K.L. hartshorn, P.A. Furman, et al. "Ribavirin antagonizes the effect of azidothymidine on HIV replication." Science. 1987; 235: 1376-1379.
56. Baba, M., R. Pawels, J. Balzarini, et al. "Ribavirin antagonizes inhibitory effects of pyrimidine-2′3′-Dideoxynucleosides but enhances inhibitory effects of purine-2′3′-dideoxynucleosides on replication of human immunodeficiency virus in vitro." Antimicrob. Agents Chemo. 1987; 31: 1613-1617.
57. Johns, D.G., G.S. Ahluwalia, D.A. Cooney, et al. "Enhancement stimulation by ribavirin of the 5′phosphorylation and anti-human immunodeficiency virus activity of purine-2-beta-fluoro-2′3′- dideoxynucleosides." Molec. Pharm. 1993; 44: 519-523.
58. Allen, L.B., L.K. Vanderslice, C.M. Fingal, et al. "Evaluation of anti-herpes virus drug combinations: Virazole plus arabinofuranosyl hypoxanthine and Virazole plus arabinofuranosyladenine." Antivir. Res. 1982; 2: 203-216.
59. Al-Nisairawi, L.A.T., V. Guadagnin, R. Jennings, and C.W. Potter. "Antiviral activity of mixtures of compounds against herpes virus." Antiviral Chem. and Chemo. 1990; 1: 125-129.
60. Ishii, H., M. Hasobe, J.G. McKee, et al. "Synergistic antiviral activity of inhibitors of S-adenosylhemocysteine hydrolase and ribavirin." Antiviral Chem and Chemother. 1993; 4: 127-130.
61. Sidwell, R.W., "In vitro and in vivo inhibition of DNA viruses by ribavirin." In: Clinical applications of ribavirin. R.A. Smith, V. Knight, and J.A.D. Smith (eds.) Acazdemic Press, New York. 1984, pp. 19-32.
62. Descamps, J., end E.R. DeClerq. "Broad-spectrum antiviral activity of pyrazofurin (Pyrazomycin)." Curr. Chemo (Proc. 10th Intl. Cong. Chemo, Zurich). W.iegenthaler and R. Luthy (eds.). 1977; 1: 354-357.
63. Galegov, G.A., A.A. Khorlin, V.M. Shobukhov, et al. "Nucleotide analogue-9(4-hydrophosphoryl-2-oxabutyl)-guanine, ribavirin (ICN) and atromantadine (ViruMertz) as effective inhibitors TK-and PAAR strains of the HSV-1 in vitro." 5th Intl. Conf. On Antiviral Res. Vancouver, BC Canada. 1992. Antiviral Res. 1992;(Supp 1):120.
64. Sidwell, R.W., R.B. Allen, G.P. Khare,et al. "Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole, ICN-1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals." Antimicrob. Agents Chemo. 1973; 3: 242-246.
65. Huggins, J.W., G.R. Kim, and K.T. McKee, Jr. "Ribavirin therapy of hemorrhagic fever with renal syndrome (HFRS) in the hantaan virus suckling mouse model" U.S.A Med. Res. Inst. of Infect. Dis. Ft. Detrick. 1984.
66. Weissenbacher, M.C., M.A. Calello, M.S. Merani, et al. "Therapeutic effect of the antiviral agent ribavirin in junin virus infection of primates." J Med. Virol. 1986; 20: 261-267.
67. Stephen, E.L., D.E. Jones, C.J. Peters, et al. "Ribavirin treatment of toga-, arena-, and bunyavirus infections in subhuman primates and other laboratory animal species." In: Ribavirin: A broad spectrum antiviral agent. R.A. Smith and W. Kirkpatrick (eds.) Academic Press, New York. 1980, pp. 169-183.
68. Patkevick, A.S., V.M. Sabynin, I.S. Lukashevich, et al. "Effect of ribavirin (Virazole) on the reproduction of some arenavirus in a cell culture." Vopr. Virusol. 1981; 2: 244-245.
69. Migus, D.O., and P. Dobos. "Effect of ribavirin on the replication of infectious pancreatic necrosis virus in fish cell cultures." J. Gen. Virol. 1980; 47: 47-57.
70. Cassidy, L.F., and J.L. Patterson. "Mechanism of La Crosse virus inhibition by ribavirin." Antimicrob. Agents Chemo. 1989; 33: 2009-2011.
71. Sidwell, R.W., J.H. Huffman, B.B. Barnett, and D.Y. Pifat. "In vitro and in vivo phlebovirus inhibition by ribavirin." Antimicrob. Agents Chemo. 1988; 32: 331-336.
72. Huffman, J.H., R.W. Sidwell, J. Gilbert, et al. "Comparison of the in vivo antipunta toro virus activity of ribavirin triacetate and ribamidine in mice." 5th Intl. Conf. On antiviral Res. Vancouver, BC Canada. Abstract Antiviral Res. 1992;(Supp 1):205.
73. Peter, C.J., P.B. Jahrling, C.T. Liu,et al. "Experimental studies of arenaviral hemorrhagic fevers." Curr. Topics in Microbiol, and Immunol. 1987; 134: 5-68.
74. Weiss, R.C., and T. Ram-Oostrom. "Inhibitory effects of ribavirin alone or combined with human alpha-interferon on feline infectious peritonitis virus replication in vitro. Vet. Microbiol. 1989;20:255-265.
75. Sidwell, R.W., J.H. Huffman, E.W. Call, et al. "Inhibition of murine hepatitis virus infection by the immunomodulator 2,3,5,6,7,8-hexahydro-2- phenyl-8-8-dimethoxy-imidazol [1,2a] pyridine (PR-879-317A)." Antimicrob. Agents Chemo. 1987; 31: 1130-1134.
76. Oxford, J.S. "Specific inhibitors of influenza virus replication as potential chemoprophylactic agents." J. Antimicrob. Chemo. 1975;1:7-23.
77. Hayden, F.G., A.N. Schleupushkin, and N.L. Pushkarskaya. "Combined interferon-alpha2, rimantadine hydrochloride and ribavirin inhibition of influenza virus replication in vitro." In: Clinical applications of ribavirin. R.A. Smith, V. Knight and J.A.D. Smith (eds.) Academic Press, New York. 1984, pp. 39-47.
78. Petrova, I.G., G.K. Vorkunova, and N.L. Pushkarskaya. "The influence of ribavirin on influenza virus B reproduction." Vopr. Virusol. 1984, No 2.
79. McCammon, J.R., and V.W. Riesser. "Effects of ribavirinon BKH-21 cells acutely or persistently infected with mumps virus." Antimicrob. Agents Chemo. 1979; 15: 356-360.
80. Sidwell, R.W., G.P. Khare, L.B. Allen, et al. "In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3 carboxamide (ribavirin) on types 1 and 3 parainfluenza virus infections." Chemo. 1975; 21: 205-220.
81. Smee, D.F. and T.R. Matthews. "Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells." Antimicrob. Agents Chemo. 1986; 30: 117-121.
82. Murphy, M.F. "In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin." J. Inf. Dis. 1978; 138: 249-251.
83. Anderson, D.O., B.K. Murray, R.K. Robins, and J.A. North. "In vitro antiviral activity of ribavirin against picornaviruses." Antiviral Chem. and Chemo. 1992;3:361-370.
84. Crance, J.M., E. Biziagos, J. Passagot, et al. "Inhibition of hepatitis A virus replication in vitro by antiviral compounds." J. Med. Virol. 1990; 31: 155-160.
85. Smee, D.F., R.W. Sidwell, S.M. Clark, et al. "Inhibition of reoviruses in vitro by selected antiviral substances." Antivir. Res. 1981; 1: 315-323.
86. Sidwell, R.W."Ribavirin: "In vitro antiviral activity." In: Ribavirin: A broad spectrum antiviral agent. R.A. Smith and W. Kirkpatrick (eds.) Academic Press, New York. 1980, pp. 23-42.
87. Smee, D.F., R.W. Sidwell, B.B. Barnett, et al. "Bioassay system for determining ribavirin levels in human serum and urine." Chemo. 1981; 27: 1-11.
88. Smee, D.F., R.W. Sidwell, and B.B. Barnett, et al. "Development of antiviral levels of ribavirin serum and urine of orally treated rats." Chemo. 1981; 27: 12-17.
89. Kitaoka, S., T. Konno, and E. DeClerq. "Comparative efficacy of broad-spectrum antiviral agents as inhibitors of rotavirus replication in vitro." Antivir. Res. 1986; 6: 57-65.
90. Smee, D.F. R.W. Sidwell, S.M. Clark, et al. "Inhibition of rotaviruses by selected antiviral substances: Mechanisms of viral inhibition and in vivo activity." Antimicrob. Agents Chemo. 1982;21:66-73.
91. Schoub, B.D., and O.W. Prozesky. "Antiviral activity of ribavirin in rotavirus gastroenteritis of mice." Antimicrob. Agents Chemo. 1977; 12: 543-544.
92. Shannon, W.M. "Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo." Ann. N.Y. Acad. Sci. 1977; 284: 472-507.
93. Savcoba, Z.D., O. Yu, V. Denisenko, et al. "effect of Virazole on multiplication and activity of RNA tumor viruses in cell cultures and in laboratory animals." Microbiol. Ah. (Kiev) 1979; 41: 170-175.
94. Jenkins, F.J., and Y.C. Chen. "Effect of ribavirin on rous sarcoma virus transformation." Antimicrob. Agents Chemo. 1981; 19: 364-368.
95. Johnston, P.B., and R.A. Eiferman. "In vitro studies on the antiviral drugs ribavirin and trifluorothymidine (FeTDR)." Meeting Abstract. In vitro. 1978; 4: 342.
96. Odelola, H.A. "Antiviral activity of Virazole on replication of viruses isolated in Nigeria." Curr. Chemotherapy (Proc. 10th Ind. Cong. Chemo. Zurich, 1977). W. Siegenthaler and R. Luthy (eds.) 1977; 1: 334-335.
97. Toltzis, P. and A.S. Huang. "Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells." Antimicrob. Agents Chemo. 1986; 29: 1010-1016.
98. Ussery, M.A. "Effect of antiviral drug ribavirin on dengue virus replication in LLC-MK 2 cells." Southeast Asian J. Trop. Med. Pub. Health, 1982; 12: 436.
99. VanTiel, F.H., T. Harmsen, W.A.M. Boere, et al. "Rapid detection of semliki forest virus replication in cell culture with peroxidase-labeled monoclonal antibodies: Determination of inhibitory concentrations of monoclonal antibodies and ribavirin." Antiviral Res. 1985; 1: 101-106.
100. Sarver, N. and V. Stollar. "Virazole prevents production of sindbis virus and virus-induced cytopathic effect in Aedes Albopictus cells." Virology. 1978; 91: 267-282.
101. Malinoski, F. and V. Stollar. "Inhibition of Sindbis virus replication in Aedes Albopictus cells by Virazole (ribavirin) and its reversal by actinomycin: a correction." Virol. 1980;102:473-476.
102. Scheidel, L.M., R.M. Durbin, and V. Stollar. "Sinbis virus mutants resistant to mycophenolic acid and ribavirin." Virology. 1987; 158: 1-7.
103. Canonico, P.G., J.S. Little, P.B. Jahrling, and E.L. Stephen. "Molecular aspects of the antiviral activity of ribavirijn on Venezuelan equine encepahlomyelitis virus." Proc. 11th ICC and 19th ICAAC Amer. Soc. of Microbiol. Curr. Chemo. Inf. Dis. 1980. pp. 1370-1372.
104. Laskin, O.L., J.A. Longstreth, C.C. Hart, et al. "Ribavirin deposition in high-risk patients for acquired immunodeficiency syndrome." Clin. Pharm. Ther. 1987; 41: 546-555.
105. Lertora, J.J.L., A.B. Rege, J.T. Lacour, et al. "Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus." Clin. Pharm. Ther. 1991;50:442-449.
106. Roberts, R.B., O.L. Laskin, J. Laurance, et al. "Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome." Clin. Pharm. Ther. 1987; 42: 365-373.
107. Paroni, R., M. Del Puppo, C. Broghi, et al. "Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4,-triazole-3- carboxamide in normal volunteers." Int. J. Clin. Ther. and Toxicol. 1989; 27: 302-307.
108. Bernstein, J.M., H. Linn, and S.D. Erk. "Comparison of oral and aerosol ribavirin regimens in the high-risk elderly." J Clin. Pharm. 1989; 29: 1128-1134.
109. Connor, E.S., S. Morrison, J. Lane, et al. "Safety, tolerance and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection." Antimicrob. Agents Chemo. 1993; 37: 532-539.
110. Crumpacker, C., G. Bubley, D. Lucey, and S. Hussey. "Ribavirin enters cerebrospinal fluid." Lancet. 1986; II (8497): 45-46.
111. Ogle, J.W., P. Tolzis, W.D. Parker, et al. "Oral ribavirin therapy for subacute sclerosing panencephalitis." J. Infec. Dis. 1989; 159: 748-750.
112. Huggins, J.W., C.M. Hsiang, T.M. Cosgriff, et al. "Prospective double blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndreome." J. Infect. Dis. 1991; 164: 1119-1127.
113. McCormick, J.B., I.J. King, P.A. Webb, et al. "Lassa fever. Effective therapy with ribavirin." New England J. Med. 1986; 314: 20-26.
114. Enria, D.A., A.M. Briggiler, S. Lewis, et al. "Preliminary report. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever." Antiviral Res. 1987; 7: 353-359.
115. Enria, D.A., and J.I. Maiztegui. "Antiviral treatment of Argentine hemorrhagic fever." Antiviral Res. 1994; 23: 23-31.
116. Ray, C.G. "Ribavirin ambivalence about an antiviral agent." AJDC 1988; 142: 488-489.
117. Ray, C.G., T.B. Iceogle, L.L. Minnich, et al. "The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis." J. Infect. Dis. 1989; 159: 829-836.
118. Liles, W.C., H. Cushings, S. Holt, et al. "Severe adenoviral nephritis following bone marrow transplantation: Successful treatment with intravenous ribavirin." Bone Marrow Transplant. 1993; 12: 409-412.
119. Murphy, G.F., D.P. Wood, Jr., J.W. McRoberts, and P.J. Henslee-Downey. "Adnovirus-associated hemorrhagic cystitis treated with intravenous ribavirin." Abstract. J. Urology. 1993; 149: 565-566.
120. Cassano, W.F. "Intravenous ribavirin therapy for adenovirus cystitis after allogenic bone marrow transplantation." Bone Marrow Transplant. 1991; 7: 247-248.
121. Englund, J., A. Pedro, M. Piedra, et al. "High dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection". J. Pediatr. 1994; 125: 635-41.
122. Avinash K. Shetty, A. Hayley, Gans, et al. "Pediatric Pneumology", 2000; 29: 69-73.